Pharmacoeconomic Analysis of Using Aprepitant Plus Standard Antiemetic Therapy for Prevention of Nausea and Vomiting Associated With Highly and Moderately Emetogenic Cancer Chemotherapy in Russia

Value in Health - United Kingdom
doi 10.1016/j.jval.2013.08.521
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy of Triple Antiemetic Therapy (Palonosetron, Dexamethasone, Aprepitant) for Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Carboplatin-Based, Moderately Emetogenic Chemotherapy.

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2016English

Ramosetron Versus Palonosetron in Combination With Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting

Cancer Research and Treatment
Cancer ResearchOncology
2020English

Effects of Serum Sodium Concentrations on Nausea and Vomiting After Moderately Emetogenic Chemotherapy

Yakugaku Zasshi
PharmacologyPharmaceutical Science
2018English

Efficacy of the Combination Use of Aprepitant and Palonosetron for Improving Nausea in Various Moderately Emetogenic Chemotherapy Regimens

BMC pharmacology & toxicology
MedicinePharmacology
2019English

Incidence of Chemotherapy-Induced Nausea and Vomiting With Moderately Emetogenic Chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) Study

Supportive Care in Cancer
Oncology
2015English

Olanzapine Combined With Standard Antiemetic Regimens for Prevention of Chemotherapy Therapy-Induced Nausea and Vomiting: A Single-Center Experience From South India

Asian Journal of Pharmaceutical and Clinical Research
PharmacologyPharmaceutical Science
2017English

Antiemetics for Chemotherapy-Induced Nausea and Vomiting Occurring Despite Prophylactic Antiemetic Therapy

Journal of Palliative Medicine
MedicineAnesthesiologyPain MedicineNursing
2011English

Cost-Effectiveness of an Aprepitant Regimen for Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients With Breast Cancer in the UK

Cancer Management and Research
Oncology
2013English

A Randomized, Placebo-Controlled Pilot Trial of Aprepitant Combined With Standard Antiemetic Therapy for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Undergoing Cyclophosphamide-Based Conditioning Regimens Prior to Hematopoietic Stem Cell Transplant (HSCT)

Bone Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy